PHARMACOKINETIC EVALUATION OF NOVEL SUSTAINED-RELEASE DOSAGE FORMS OF VALPROIC ACID IN HUMANS

被引：23

作者：

BIALER, M

FRIEDMAN, M

DUBROVSKY, J

RAZ, I

ABRAMSKY, O

机构：

[1] HADASSAH MED CTR,DEPT MED B,IL-91120 JERUSALEM,ISRAEL

[2] HADASSAH MED CTR,DEPT NEUROL,IL-91120 JERUSALEM,ISRAEL

来源：

关键词：

D O I：

10.1002/bdd.2510060406

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：401 / 411

页数：11

共 24 条

[1] EFFECT OF SUSTAINED-RELEASE ON THE PHARMACOKINETICS OF VALPROIC ACID IN THE DOG
BIALER, M
FRIEDMAN, M
DUBROVSKY, J
[J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1984, 20 (1-2) : 53 - 63
[2] RAPID GAS-CHROMATOGRAPHIC ASSAY FOR MONITORING VALPROIC ACID AND VALPROMIDE IN PLASMA
BIALER, M
FRIEDMAN, M
RUBINSTEIN, A
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (07) : 991 - 993
[3] COMPARATIVE PHARMACOKINETIC ANALYSIS OF A NOVEL SUSTAINED-RELEASE DOSAGE FORM OF VALPROIC ACID IN DOGS
BIALER, M
FRIEDMAN, M
DUBROVSKY, J
[J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1984, 5 (01) : 1 - 10
[4] VALPROIC ACID - REVIEW OF A NEW ANTIEPILEPTIC DRUG
BRUNI, J
WILDER, BJ
[J]. ARCHIVES OF NEUROLOGY, 1979, 36 (07) : 393 - 398
[5] CENRARD B, 1981, ADV EPILEPTOLOGY, P541
[6] CLOYD JC, 1981, INDIVIDUALIZING DRUG, V2, P541
[7] COVANIS A, 1980, DEV MED CHILD NEUROL, V22, P202
[8] Gibaldi M., 1982, PHARMACOKINETICS, P445
[9] GIBALDI M, 1982, PHARMACOKINETICS, P155
[10] GUELEN JM, 1978, RATIONAL ANTIEPILEPT, P125